INT232361

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.49
First Reported 2007
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 3
Total Number 3
Disease Relevance 0.11
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

mitochondrion (Agxt) peroxisome (Agxt)
Agxt (Rattus norvegicus)
Pain Link Frequency Relevance Heat
cva 6 5.00 Very Low Very Low Very Low
Neuronal excitability 3 5.00 Very Low Very Low Very Low
Action potential 3 5.00 Very Low Very Low Very Low
eye pain 2 5.00 Very Low Very Low Very Low
fibrosis 2 5.00 Very Low Very Low Very Low
Inflammation 2 5.00 Very Low Very Low Very Low
intrathecal 2 5.00 Very Low Very Low Very Low
vincristine 2 5.00 Very Low Very Low Very Low
imagery 2 5.00 Very Low Very Low Very Low
hyperexcitability 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Glioma 74 57.04 Quite High
Cancer 62 47.88 Quite Low
Anaplastic Astrocytoma 4 32.48 Quite Low
Primitive Neuroectodermal Tumors 2 31.76 Quite Low
Infection 10 17.84 Low Low
Glioblastoma 28 5.00 Very Low Very Low Very Low
Toxicity 20 5.00 Very Low Very Low Very Low
Brain Tumor 18 5.00 Very Low Very Low Very Low
Recurrence 14 5.00 Very Low Very Low Very Low
Pressure And Volume Under Development 12 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The repair of the chloroethyl adducts is conducted by O6-alkylguanine-DNA alkyltransferase (AGT or MGMT).
Positive_regulation (alkyltransferase) of Gene_expression (alkyltransferase) of AGT
1) Confidence 0.49 Published 2007 Journal Therapeutics and Clinical Risk Management Section Body Doc Link PMC2376068 Disease Relevance 0.06 Pain Relevance 0
The repair of the chloroethyl adducts is conducted by O6-alkylguanine-DNA alkyltransferase (AGT or MGMT).
Positive_regulation (conducted) of Gene_expression (alkyltransferase) of AGT
2) Confidence 0.49 Published 2007 Journal Therapeutics and Clinical Risk Management Section Body Doc Link PMC2376068 Disease Relevance 0.06 Pain Relevance 0
In accordance with these results, our SPT studies revealed that both treatments significantly reduced the synaptic dwell time of Eag1 (0.52±0.04 s, n?
Positive_regulation (accordance) of Gene_expression (studies) of SPT
3) Confidence 0.04 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2810327 Disease Relevance 0 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox